A detailed history of Yhb Investment Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Yhb Investment Advisors, Inc. holds 3,284 shares of NVO stock, worth $348,530. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,284
Previous 2,950 11.32%
Holding current value
$348,530
Previous $421,000 7.13%
% of portfolio
0.03%
Previous 0.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$119.07 - $145.42 $39,769 - $48,570
334 Added 11.32%
3,284 $391,000
Q2 2024

Aug 01, 2024

BUY
$122.71 - $146.91 $30,677 - $36,727
250 Added 9.26%
2,950 $421,000
Q1 2024

Aug 14, 2024

SELL
$102.11 - $135.92 $25,527 - $33,980
-250 Reduced 8.47%
2,700 $346,000
Q1 2024

Apr 26, 2024

BUY
$102.11 - $135.92 $275,697 - $366,983
2,700 New
2,700 $346,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $240B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Yhb Investment Advisors, Inc. Portfolio

Follow Yhb Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.